Iovance Biotherapeutics, Inc. (IOVA): Cash & Equivalents
$163.08M
As of 2025-12-31
$110.77M
As of 2026-06-30
-11.1%
3-year compound annual growth
+19.4%
5-year compound annual growth
+17.1%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $163.08M | +41.0% | 2026-02-24, Balance as of period end |
| 2024-12-31 | $115.69M | +0.7% | 2026-02-24, Balance as of period end |
| 2023-12-31 | $114.89M | -50.4% | 2026-02-24, Balance as of period end |
| 2022-12-31 | $231.73M | +196.2% | 2025-02-27, Balance as of period end |
| 2021-12-31 | $78.23M | +16.2% | 2024-02-28, Balance as of period end |
| 2020-12-31 | $67.33M | +382.0% | 2023-02-28, Balance as of period end |
| 2019-12-31 | $13.97M | -83.0% | 2022-02-24, Balance as of period end |
| 2018-12-31 | $82.15M | -43.5% | 2021-02-25, Balance as of period end |
| 2017-12-31 | $145.37M | +36.2% | 2020-02-25, Balance as of period end |
| 2016-12-31 | $106.72M | +217.7% | 2019-02-28, Balance as of period end |
| 2015-12-31 | $33.59M | -25.2% | 2018-03-12, Balance as of period end |
| 2014-12-31 | $44.91M | +128.3% | 2017-03-09, Balance as of period end |
| 2013-12-31 | $19.67M | n/a | 2016-03-11, Balance as of period end |
| 2012-12-31 | $0 | -100.0% | 2014-03-28, Balance as of period end |
| 2011-12-31 | $510.2K | -60.5% | 2014-03-28, Balance as of period end |
| 2010-12-31 | $1.29M | n/m | 2013-09-23, Balance as of period end |
| 2009-12-31 | $8.3K | +184.2% | 2012-03-30, Balance as of period end |
| 2008-12-31 | $2.9K | n/a | 2012-03-30, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Iovance Biotherapeutics, Inc. (IOVA) | 2025-12-31 | $163.08M | +41.0% |
| Vericel Corp (VCEL) | 2025-12-31 | $100.09M | +34.3% |
| Adaptive Biotechnologies Corp (ADPT) | 2025-12-31 | $70.50M | +47.1% |
| Twist Bioscience Corp (TWST) | 2025-09-30 | $183.05M | -19.1% |
| Krystal Biotech, Inc. (KRYS) | 2025-12-31 | $496.30M | +43.9% |
| Adaptimmune Therapeutics PLC (ADAPY) | 2024-12-31 | $91.14M | -36.7% |
| Immunocore Holdings plc (IMCR) | 2025-12-31 | $467.71M | +2.6% |
| REGENXBIO Inc. (RGNX) | 2025-12-31 | $34.47M | -40.1% |
| Ginkgo Bioworks Holdings, Inc. (DNA) | 2025-12-31 | $167.20M | -70.2% |
Compare IOVA, VCEL, ADPT, TWST side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗